drugset
drugset / Trial / NCT07476157

A Study to Evaluate the Safety and Pharmacokinetics of AD-118 and AD-1181 in Healthy Adult Subjects

NCT07476157 ↗

Phase 1 Not yet recruiting 70 enrolled Addpharma Inc.
RandomizedCrossoverOpen-labelTreatment

Summary

A Study to Evaluate the Safety and Pharmacokinetics of AD-118 and AD-1181 Under Fasted Conditions in Healthy Adult Subjects

Timeline

Start
2026-04
Primary completion
2026-05
Completion
2026-05

Drugs

EvaluationDrugModalityDoseRoute
Subject AD-118 Unknown — Oral
Subject AD-1181 Unknown — Oral

Indications

heart failure